Abstract
In maintaining organismal homeostasis, gut immunity plays a crucial role. The coordination between the microbiota and the immune system through bidirectional interactions regulates the impact of microorganisms on the host. Our research focused on understanding the relationship between substantial changes in jejunal intestinal flora and metabolites and intestinal immunity during porcine epidemic diarrhea virus (PEDV) infection in piglets. We discovered that Lactobacillus rhamnosus GG (LGG) could effectively prevent PEDV infection in piglets. Further investigation revealed that LGG metabolites interact with type 3 innate lymphoid cells (ILC3) in the jejunum of piglets through the aryl hydrocarbon receptor (AhR). This interaction promotes the activation of ILC3 cells and the production of interleukin-22 (IL-22). Subsequently, IL-22 facilitates the proliferation of IPEC-J2 cells and activates the STAT3 signaling pathway, thereby preventing PEDV infection. Moreover, the AhR receptor exerts its influence on various cell types within organoids, including intestinal stem cells (ISCs), Paneth cells, and enterocytes, fostering their growth and development, suggesting a broad impact of AhR on intestinal health. In conclusion, our study demonstrates the ability of LGG to modulate intestinal immunity and effectively prevent PEDV infection in piglets. These findings highlight the potential application of LGG as a preventive measure against viral infections in livestock.
Introduction
Porcine Epidemic Diarrhea Virus (PEDV) is a significant threat to the global swine industry, causing severe diarrhea, dehydration, and near 100% mortality in neonatal piglets. While the protective role of a healthy gut microbiome is well-documented, the precise molecular mechanisms connecting specific beneficial bacteria to the host's antiviral immune response have remained largely mysterious. This study identifies a specific "cross-talk" pathway where the probiotic Lactobacillus rhamnosus GG (LGG) protects piglets by activating the Aryl Hydrocarbon Receptor (AhR) on Type 3 Innate Lymphoid Cells (ILC3s), triggering a protective wave of Interleukin-22 (IL-22) that repairs the gut barrier and blocks viral replication.
Methods and Data Integration
The researchers employed a multi-modal approach combining in vivo piglet models with ex vivo systems to map the intestinal immune landscape:
- Single-Cell RNA Sequencing (scRNA-seq): Used to map the immune landscape of the piglet intestine, identifying specific cell clusters and their receptor expressions (GSE175411, PRJNA907920).
- Porcine Jejunal Organoids: "Mini-guts" were grown from piglet tissue to observe how stem cells and epithelial layers respond to immune signals in a controlled environment.
- Metabolomics & Nanoflow Cytometry: These techniques isolated and analyzed Extracellular Vesicles (EVs) produced by LGG, identifying specific indole compounds (like I3A) that act as signaling ligands.
- Microbiome Analysis: 16S rRNA sequencing tracked changes in microbial diversity during infection and probiotic treatment (PRJNA526581, PRJNA1048561, PRJNA1048648).
Key Insights: The LGG-AhR-ILC3 Axis
The study revealed that porcine ILC3s are highly enriched with the Aryl Hydrocarbon Receptor (AhR), making them uniquely sensitive to metabolites derived from the amino acid tryptophan. LGG packages these metabolites, such as indole-3-aldehyde (I3A), into extracellular vesicles (EVs). These "cargo ships" efficiently deliver signals to ILC3s deep in the gut lining.
Once activated by LGG's indoles, ILC3s secrete IL-22, which binds to epithelial cells and activates the STAT3 signaling pathway. This mechanism provides two-fold protection:
- Tissue Repair: It stimulates the proliferation of intestinal stem cells (ISCs) and Paneth cells, maintaining the structural integrity of the intestinal villi.
- Antiviral Defense: It triggers the release of antiviral proteins (IFN-λ) and antimicrobial peptides (Reg3b/g), effectively inhibiting PEDV replication.
Results and Efficacy
Experimental results confirmed the potency of this probiotic intervention:
- Reduced Viral Load: Piglets supplemented with LGG showed significantly lower viral copy numbers in the duodenum, jejunum, and ileum compared to infected controls.
- Structural Integrity: Histopathology demonstrated that LGG prevented the "villus atrophy" typically seen in PEDV. The ratio of villus height to crypt depth—a key metric of gut health—was significantly preserved.
- Mechanistic Validation: In organoid models, the addition of LGG-derived EVs and ILC3s led to increased expression of marker genes for intestinal stem cells (Lgr5) and Paneth cells (Lyz1). The use of an AhR antagonist (CH-223191) abolished these protective effects, confirming AhR as the essential mediator.
Conclusion and Future Directions
This research provides a clear blueprint for how LGG modulates intestinal immunity to prevent PEDV infection. These findings highlight the potential for LGG and its metabolites to be used as preventive measures against viral infections in livestock. Future work is needed to explore microbial synergies within the gut ecosystem and to optimize the specific metabolite "cocktails" for broader application against other enteric viruses.
Summary updated